Olsalazine

Olsalazine
Systematic (IUPAC) name
5-[(2Z)-2-(3-carboxy-4-oxocyclohexa-2,5-dien-1-ylidene)hydrazino]-2-hydroxybenzoic acid
Clinical data
Trade names Dipentum
AHFS/Drugs.com monograph
MedlinePlus a601088
Pregnancy
category
  • US: C (Risk not ruled out)
Legal status
Legal status
Pharmacokinetic data
Protein binding 99%
Biological half-life 0.9 hours
Identifiers
CAS Number 15722-48-2 YesY
ATC code A07EC03 (WHO)
PubChem CID 6003770
DrugBank DB01250 YesY
ChemSpider 10642377 YesY
UNII ULS5I8J03O YesY
KEGG D00727 N
ChEMBL CHEMBL571540 N
Chemical data
Formula C14H10N2O6
Molar mass 302.239g/mol
 NYesY (what is this?)  (verify)

Olsalazine is an anti-inflammatory drug used in the treatment of inflammatory bowel disease such as ulcerative colitis. It is sold under the name Dipentum.

The chemical name is 3,3' -azobis (6-hydroxybenzoate)salicylic acid. It is sold as the disodium salt.

Like balsalazide, olsalazine is believed to deliver mesalazine, or 5-aminosalicylic acid (5-ASA), past the small intestine, directly to the large intestine, which is the active site of disease in ulcerative colitis.

History

Olsalazine gained Food and Drug Administration (FDA) approval in 1990.

Supply

The drug is supplied by UCB Pharma.

Other indications

The Australian biotech company Giaconda has developed a combination therapy for treating constipation-predominant irritable bowel syndrome that uses olsalazine and the anti-gout drug colchicine.

External links


This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.